IVD抗体のグローバル市場展望 2023年-2029年：mAb、pAb、rAb

■ 英語タイトル：IVD Antibody Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY7770）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY7770
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：75
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[IVD抗体のグローバル市場展望 2023年-2029年：mAb、pAb、rAb]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のIVD抗体市場規模と予測を収録しています。・世界のIVD抗体市場：売上、2018年-2023年、2024年-2029年
・世界のIVD抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のIVD抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「mAb」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

IVD抗体のグローバル主要企業は、BD PharMingen、 Abcam、 R&D Systems、 Cell Signaling Technology、 Affymatrix、 BioLegend、 Santa Cruz Biotechnologies、 Beckman Coulter、 Roche/Ventanaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、IVD抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のIVD抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界のIVD抗体市場：タイプ別市場シェア、2022年
・mAb、pAb、rAb

世界のIVD抗体市場：用途別、2018年-2023年、2024年-2029年
世界のIVD抗体市場：用途別市場シェア、2022年
・RIA、ELISA、CLIA、LFIA、その他

世界のIVD抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界のIVD抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるIVD抗体のグローバル売上、2018年-2023年
・主要企業におけるIVD抗体のグローバル売上シェア、2022年
・主要企業におけるIVD抗体のグローバル販売量、2018年-2023年
・主要企業におけるIVD抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
BD PharMingen、 Abcam、 R&D Systems、 Cell Signaling Technology、 Affymatrix、 BioLegend、 Santa Cruz Biotechnologies、 Beckman Coulter、 Roche/Ventana

*************************************************************

・調査・分析レポートの概要
IVD抗体市場の定義
市場セグメント
世界のIVD抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のIVD抗体市場規模
世界のIVD抗体市場規模：2022年 VS 2029年
世界のIVD抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのIVD抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のIVD抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：mAb、pAb、rAb
IVD抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：RIA、ELISA、CLIA、LFIA、その他
IVD抗体の用途別グローバル売上・予測

・地域別市場分析
地域別IVD抗体市場規模 2022年と2029年
地域別IVD抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
BD PharMingen、 Abcam、 R&D Systems、 Cell Signaling Technology、 Affymatrix、 BioLegend、 Santa Cruz Biotechnologies、 Beckman Coulter、 Roche/Ventana
...

IVD Antibody
This report aims to provide a comprehensive presentation of the global market for IVD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibody. This report contains market size and forecasts of IVD Antibody in global, including the following market information:
Global IVD Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global IVD Antibody Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five IVD Antibody companies in 2022 (%)
The global IVD Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
mAb Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of IVD Antibody include BD PharMingen, Abcam, R&D Systems, Cell Signaling Technology, Affymatrix, BioLegend, Santa Cruz Biotechnologies, Beckman Coulter and Roche/Ventana, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IVD Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IVD Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global IVD Antibody Market Segment Percentages, by Type, 2022 (%)
mAb
pAb
rAbs
Global IVD Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global IVD Antibody Market Segment Percentages, by Application, 2022 (%)
RIA
ELISA
CLIA
LFIA
Other
Global IVD Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global IVD Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IVD Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies IVD Antibody revenues share in global market, 2022 (%)
Key companies IVD Antibody sales in global market, 2018-2023 (Estimated), (K Units)
Key companies IVD Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD PharMingen
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana
Outline of Major Chapters:
Chapter 1: Introduces the definition of IVD Antibody, market overview.
Chapter 2: Global IVD Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of IVD Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IVD Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global IVD Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 IVD Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IVD Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IVD Antibody Overall Market Size
2.1 Global IVD Antibody Market Size: 2022 VS 2029
2.2 Global IVD Antibody Revenue, Prospects & Forecasts: 2018-2029
2.3 Global IVD Antibody Sales: 2018-2029
3 Company Landscape
3.1 Top IVD Antibody Players in Global Market
3.2 Top Global IVD Antibody Companies Ranked by Revenue
3.3 Global IVD Antibody Revenue by Companies
3.4 Global IVD Antibody Sales by Companies
3.5 Global IVD Antibody Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 IVD Antibody Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers IVD Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 IVD Antibody Players in Global Market
3.8.1 List of Global Tier 1 IVD Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 IVD Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global IVD Antibody Market Size Markets, 2022 & 2029
4.1.2 mAb
4.1.3 pAb
4.1.4 rAbs
4.2 By Type – Global IVD Antibody Revenue & Forecasts
4.2.1 By Type – Global IVD Antibody Revenue, 2018-2023
4.2.2 By Type – Global IVD Antibody Revenue, 2024-2029
4.2.3 By Type – Global IVD Antibody Revenue Market Share, 2018-2029
4.3 By Type – Global IVD Antibody Sales & Forecasts
4.3.1 By Type – Global IVD Antibody Sales, 2018-2023
4.3.2 By Type – Global IVD Antibody Sales, 2024-2029
4.3.3 By Type – Global IVD Antibody Sales Market Share, 2018-2029
4.4 By Type – Global IVD Antibody Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IVD Antibody Market Size, 2022 & 2029
5.1.2 RIA
5.1.3 ELISA
5.1.4 CLIA
5.1.5 LFIA
5.1.6 Other
5.2 By Application – Global IVD Antibody Revenue & Forecasts
5.2.1 By Application – Global IVD Antibody Revenue, 2018-2023
5.2.2 By Application – Global IVD Antibody Revenue, 2024-2029
5.2.3 By Application – Global IVD Antibody Revenue Market Share, 2018-2029
5.3 By Application – Global IVD Antibody Sales & Forecasts
5.3.1 By Application – Global IVD Antibody Sales, 2018-2023
5.3.2 By Application – Global IVD Antibody Sales, 2024-2029
5.3.3 By Application – Global IVD Antibody Sales Market Share, 2018-2029
5.4 By Application – Global IVD Antibody Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global IVD Antibody Market Size, 2022 & 2029
6.2 By Region – Global IVD Antibody Revenue & Forecasts
6.2.1 By Region – Global IVD Antibody Revenue, 2018-2023
6.2.2 By Region – Global IVD Antibody Revenue, 2024-2029
6.2.3 By Region – Global IVD Antibody Revenue Market Share, 2018-2029
6.3 By Region – Global IVD Antibody Sales & Forecasts
6.3.1 By Region – Global IVD Antibody Sales, 2018-2023
6.3.2 By Region – Global IVD Antibody Sales, 2024-2029
6.3.3 By Region – Global IVD Antibody Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America IVD Antibody Revenue, 2018-2029
6.4.2 By Country – North America IVD Antibody Sales, 2018-2029
6.4.3 US IVD Antibody Market Size, 2018-2029
6.4.4 Canada IVD Antibody Market Size, 2018-2029
6.4.5 Mexico IVD Antibody Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe IVD Antibody Revenue, 2018-2029
6.5.2 By Country – Europe IVD Antibody Sales, 2018-2029
6.5.3 Germany IVD Antibody Market Size, 2018-2029
6.5.4 France IVD Antibody Market Size, 2018-2029
6.5.5 U.K. IVD Antibody Market Size, 2018-2029
6.5.6 Italy IVD Antibody Market Size, 2018-2029
6.5.7 Russia IVD Antibody Market Size, 2018-2029
6.5.8 Nordic Countries IVD Antibody Market Size, 2018-2029
6.5.9 Benelux IVD Antibody Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia IVD Antibody Revenue, 2018-2029
6.6.2 By Region – Asia IVD Antibody Sales, 2018-2029
6.6.3 China IVD Antibody Market Size, 2018-2029
6.6.4 Japan IVD Antibody Market Size, 2018-2029
6.6.5 South Korea IVD Antibody Market Size, 2018-2029
6.6.6 Southeast Asia IVD Antibody Market Size, 2018-2029
6.6.7 India IVD Antibody Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America IVD Antibody Revenue, 2018-2029
6.7.2 By Country – South America IVD Antibody Sales, 2018-2029
6.7.3 Brazil IVD Antibody Market Size, 2018-2029
6.7.4 Argentina IVD Antibody Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa IVD Antibody Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa IVD Antibody Sales, 2018-2029
6.8.3 Turkey IVD Antibody Market Size, 2018-2029
6.8.4 Israel IVD Antibody Market Size, 2018-2029
6.8.5 Saudi Arabia IVD Antibody Market Size, 2018-2029
6.8.6 UAE IVD Antibody Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BD PharMingen
7.1.1 BD PharMingen Company Summary
7.1.2 BD PharMingen Business Overview
7.1.3 BD PharMingen IVD Antibody Major Product Offerings
7.1.4 BD PharMingen IVD Antibody Sales and Revenue in Global (2018-2023)
7.1.5 BD PharMingen Key News & Latest Developments
7.2 Abcam
7.2.1 Abcam Company Summary
7.2.2 Abcam Business Overview
7.2.3 Abcam IVD Antibody Major Product Offerings
7.2.4 Abcam IVD Antibody Sales and Revenue in Global (2018-2023)
7.2.5 Abcam Key News & Latest Developments
7.3 R&D Systems
7.3.1 R&D Systems Company Summary
7.3.2 R&D Systems Business Overview
7.3.3 R&D Systems IVD Antibody Major Product Offerings
7.3.4 R&D Systems IVD Antibody Sales and Revenue in Global (2018-2023)
7.3.5 R&D Systems Key News & Latest Developments
7.4 Cell Signaling Technology
7.4.1 Cell Signaling Technology Company Summary
7.4.2 Cell Signaling Technology Business Overview
7.4.3 Cell Signaling Technology IVD Antibody Major Product Offerings
7.4.4 Cell Signaling Technology IVD Antibody Sales and Revenue in Global (2018-2023)
7.4.5 Cell Signaling Technology Key News & Latest Developments
7.5 Affymatrix
7.5.1 Affymatrix Company Summary
7.5.2 Affymatrix Business Overview
7.5.3 Affymatrix IVD Antibody Major Product Offerings
7.5.4 Affymatrix IVD Antibody Sales and Revenue in Global (2018-2023)
7.5.5 Affymatrix Key News & Latest Developments
7.6 BioLegend
7.6.1 BioLegend Company Summary
7.6.2 BioLegend Business Overview
7.6.3 BioLegend IVD Antibody Major Product Offerings
7.6.4 BioLegend IVD Antibody Sales and Revenue in Global (2018-2023)
7.6.5 BioLegend Key News & Latest Developments
7.7 Santa Cruz Biotechnologies
7.7.1 Santa Cruz Biotechnologies Company Summary
7.7.2 Santa Cruz Biotechnologies Business Overview
7.7.3 Santa Cruz Biotechnologies IVD Antibody Major Product Offerings
7.7.4 Santa Cruz Biotechnologies IVD Antibody Sales and Revenue in Global (2018-2023)
7.7.5 Santa Cruz Biotechnologies Key News & Latest Developments
7.8 Beckman Coulter
7.8.1 Beckman Coulter Company Summary
7.8.2 Beckman Coulter Business Overview
7.8.3 Beckman Coulter IVD Antibody Major Product Offerings
7.8.4 Beckman Coulter IVD Antibody Sales and Revenue in Global (2018-2023)
7.8.5 Beckman Coulter Key News & Latest Developments
7.9 Roche/Ventana
7.9.1 Roche/Ventana Company Summary
7.9.2 Roche/Ventana Business Overview
7.9.3 Roche/Ventana IVD Antibody Major Product Offerings
7.9.4 Roche/Ventana IVD Antibody Sales and Revenue in Global (2018-2023)
7.9.5 Roche/Ventana Key News & Latest Developments
8 Global IVD Antibody Production Capacity, Analysis
8.1 Global IVD Antibody Production Capacity, 2018-2029
8.2 IVD Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global IVD Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IVD Antibody Supply Chain Analysis
10.1 IVD Antibody Industry Value Chain
10.2 IVD Antibody Upstream Market
10.3 IVD Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IVD Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

IVD抗体のグローバル市場展望 2023年-2029年：mAb、pAb、rAb

グローバル市場調査会社